PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-95.21%
Negative revenue growth is a classic Benjamin Graham warning sign. While possibly cyclical, verify Market Share trends and Competitive Position.
31.39%
Cost of revenue up >15% signals severe cost pressure. Seth Klarman would demand evidence of corresponding revenue growth.
-116.81%
Negative gross profit growth is a serious warning sign. Benjamin Graham would demand thorough analysis of pricing power and cost structure.
-451.18%
Negative gross margin growth suggests serious pricing or cost issues. Benjamin Graham would demand thorough analysis.
6.71%
R&D growth 5-10% suggests significant investment. Howard Marks would investigate if returns justify increased spending.
86.34%
G&A growth above 5% signals concerning overhead expansion. Seth Klarman would demand justification for increased costs.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.34%
Operating expenses growth above 10% signals concerning cost expansion. Seth Klarman would demand justification.
29.34%
Total costs growth above 5% signals concerning expansion. Seth Klarman would demand justification.
-100.00%
Negative interest expense growth needs verification. Benjamin Graham would examine debt reduction strategy.
31.39%
D&A growth above 10% signals heavy asset expansion. Seth Klarman would demand evidence of future payoff.
-52.58%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
-3087.14%
Negative EBITDA margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
-52.01%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-3075.40%
Negative operating margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
137.14%
Other expenses growth above 30% signals concerning expansion. Seth Klarman would scrutinize unusual items.
-51.43%
Negative pre-tax income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-3063.27%
Negative pre-tax margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
100.00%
Tax expense growth above 20% signals concerning expansion. Seth Klarman would scrutinize tax strategy.
-52.47%
Negative net income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-3085.00%
Negative net margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
-43.48%
Negative EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
-43.48%
Negative diluted EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
7.17%
Share increase above 2% signals significant dilution. Seth Klarman would demand explanation.
7.17%
Diluted share increase above 2% signals significant dilution. Seth Klarman would demand explanation.